Orthopaedic knee implant price: Proven cap extended to 2027
Orthopaedic knee implant price cap extended until January 2027, ensuring affordability and access for patients needing essential treatments.
Orthopaedic knee implant price cap extended until January 2027, ensuring affordability and access for patients needing essential treatments.
API expansion strategy is driving RPG Life Sciences' growth with new acquisitions on the horizon.
Biosimilars portfolio acquisition is reshaping the market with Adalvo's latest move.
Cancer drug price cut brings new rates for 543 brands effective November 9. Discover the details now.
Weight loss drug price cut is making headlines. Discover if this change is worth it for consumers looking for affordable options.
Cevimeline HCl approval marks a significant milestone for Cosette. Discover its implications for the pharma industry.
FDA approval schizophrenia treatment brings new hope for patients struggling with mental health issues.
Cancer drug prices may decrease as the government plans a 30% trade margin cap, offering potential savings for patients.
Aurobindo Pharma USFDA approval has sparked a rally, reaching a new 52-week high. Discover what this means for investors.
FDA approval apixaban suspension marks a significant advancement in treatment options.